This role offers the opportunity to join a multidisciplinary team at RayzeBio, a subsidiary of Bristol Myers Squibb, to develop transformative radiopharmaceutical therapies for cancer patients.
Base: $107,904 - $130,754 annually; Bonus/Equity: Additional incentive cash and stock opportunities available; Benefits: Medical, dental, vision, 401(k), paid time off, and wellness programs
Must-have
Nice-to-have
Not specified